Broussonetia papyrifera
Broussonetia papyrifera
Broussonetia papyrifera, commonly known as paper mulberry, is a plant traditionally used for various purposes such as paper production and traditional Chinese medicine. However, there are no specific traditional uses or practices recorded for this plant in any particular tradition. Scientific evidence suggests that Broussonetia papyrifera has potential benefits, with studies indicating its bioactive constituent BCA acts as a potent β-amyloid aggregation inhibitor, improving cognitive functions in mice models. Additionally, extracts from the fruit have shown promise in alleviating Alzheimer's pathogenesis by disrupting the vicious cycle of Aβ and oxidative stress, both in C. elegans and cellular models. No major safety concerns or drug interactions have been recorded for Broussonetia papyrifera, but further research is needed to confirm these findings comprehensively.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- WD + Bic elicited different early stress responses in B. papyrifera and M. alba compared to WD alone, without uniformly intensifying stress.
- Broussonetia papyrifera was the most dominant pollen type, comprising 77.65% of the total pollen in Chengdu's urban area during spring.
- The ethyl acetate fraction of Broussonetia papyrifera fruit extract attenuated Alzheimer's pathogenesis by disrupting the vicious cycle of Aβ and oxidative stress in both C. elegans and cellular models.
- BCA, a bioactive constituent of Broussonetia papyrifera, is a potent β-amyloid aggregation inhibitor that improves cognitive function in scopolamine-induced mice.
Frequently asked questions
What is Broussonetia papyrifera?
Broussonetia papyrifera (Broussonetia papyrifera) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Broussonetia papyrifera?
4 sourced findings are recorded for Broussonetia papyrifera; the strongest carries evidence grade D. For example: WD + Bic elicited different early stress responses in B. papyrifera and M. alba compared to WD alone, without uniformly intensifying stress.
How strong is the evidence for Broussonetia papyrifera?
The strongest finding for Broussonetia papyrifera carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Broussonetia papyrifera safe? What are the side effects?
No major safety issues are recorded for Broussonetia papyrifera in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Broussonetia papyrifera interact with medications?
No drug interactions are recorded for Broussonetia papyrifera in our sources. This does not rule them out — check with a pharmacist.
Is Broussonetia papyrifera a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Broussonetia papyrifera fruit extract attenuates Alzheimer's pathogenesis via disrupting the vicious cycle of Aβ and oxidative stress in C. elegans and cellular models. literature abstract metadata
- T2 [Annual monitoring and analysis of airborne pollen in Chengdu urban area of Sichuan Province]. literature abstract metadata
- T2 Leaf electrophysiological readouts reveal bicarbonate-associated shifts in early water-deficit response modes in Broussonetia papyrifera and Morus alba. literature abstract metadata
- T2 Broussochalcone A alleviates cognitive impairment in scopolamine-induced mice as a potent β-amyloid aggregation inhibitor and changes blood and brain metabolite profiles. literature abstract metadata